Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
October 23, 2017
Arthur D. Little AB

Seizing the digital opportunities in pharma

Preparing your organization and monetizing the digital technologies

Seizing the digital opportunities in pharma

Preparing your organization and monetizing the digital technologies

-
Arthur D. Little AB
-
October 23, 2017

Preparing your organization and monetizing the digital technologies

Digitalization in healthcare is booming, and creates unprecedented opportunities to further improve health standards and accessibility. Still, large pharma companies are confronted with the challenge of selecting, funding and developing the right projects among myriad initiatives: What is the right starting point and framework to compete? What to prioritize? How to make digital pervasive in the organization? How to monetize it?

Based on our recent experience, we at Arthur D. Little have developed a pragmatic framework to characterize and evaluate the opportunities, define and prioritize the related initiatives, and ensure that there is a clear business rationale - along with its financial business case - supporting them.We share below some of the learnings from our recent work with pharmaceutical companies in this area.

Last updated:
October 23, 2017

Arthur D. Little AB

Arthur D. Little is one of the wolrd's premier management consulting firms with offices in more than 30 countries. To the Healthcare and Life Science industry, we provide management consulting services in; strategy development and implementation, transformation change management, innovation management, performance improvement, opportunity assessment

Click here to read more about us!
Other articles published by
Arthur D. Little AB

Preparing your organization and monetizing the digital technologies

Digitalization in healthcare is booming, and creates unprecedented opportunities to further improve health standards and accessibility. Still, large pharma companies are confronted with the challenge of selecting, funding and developing the right projects among myriad initiatives: What is the right starting point and framework to compete? What to prioritize? How to make digital pervasive in the organization? How to monetize it?

Based on our recent experience, we at Arthur D. Little have developed a pragmatic framework to characterize and evaluate the opportunities, define and prioritize the related initiatives, and ensure that there is a clear business rationale - along with its financial business case - supporting them.We share below some of the learnings from our recent work with pharmaceutical companies in this area.

Last updated:
October 23, 2017

Arthur D. Little AB

Arthur D. Little is one of the wolrd's premier management consulting firms with offices in more than 30 countries. To the Healthcare and Life Science industry, we provide management consulting services in; strategy development and implementation, transformation change management, innovation management, performance improvement, opportunity assessment

Click here to read more about us!
Other articles published by
Arthur D. Little AB